Fmr LLC Zomedica Corp. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Zomedica Corp. stock. As of the latest transaction made, Fmr LLC holds 4,527 shares of ZOM stock, worth $543. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,527

Previous 6,183 26.78%

Holding current value

$543

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.12 - $0.18 $198 - $298	-1,656 Reduced 26.78%	4,527 $0
Q1 2024 May 13, 2024	SELL	$0.12 - $0.19 $37,878 - $59,974	-315,655 Reduced 98.08%	6,183 $0
Q4 2023 Feb 13, 2024	BUY	$0.15 - $0.22 $15,201 - $22,295	101,342 Added 45.96%	321,838 $64,000
Q3 2023 Nov 13, 2023	BUY	$0.16 - $0.23 $31,892 - $45,845	199,328 Added 941.65%	220,496 $37,000
Q2 2023 Aug 11, 2023	BUY	$0.19 - $0.22 $907 - $1,050	4,774 Added 29.12%	21,168 $4,000
Q1 2023 May 11, 2023	SELL	$0.16 - $0.29 $34,114 - $61,832	-213,215 Reduced 92.86%	16,394 $3,000
Q4 2022 Feb 13, 2023	BUY	$0.16 - $0.25 $36,607 - $57,199	228,799 Added 28246.79%	229,609 $36,000
Q3 2022 Nov 10, 2022	BUY	$0.2 - $0.38 $62 - $117	310 Added 62.0%	810 $0
Q2 2022 Aug 12, 2022	SELL	$0.2 - $0.34 $921 - $1,565	-4,605 Reduced 90.21%	500 $0
Q1 2022 May 13, 2022	BUY	$0.28 - $0.4 $1,429 - $2,042	5,105 New	5,105 $2,000
Q4 2021 Feb 14, 2022	SELL	$0.31 - $0.58 $2,183 - $4,085	-7,044 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$0.46 - $0.81 $3,231 - $5,689	7,024 Added 35120.0%	7,044 $3,000
Q2 2021 Aug 13, 2021	BUY	$0.72 - $1.46 $14 - $29	20 New	20 $0

Others Institutions Holding ZOM

# of Institutions

Shares Held

81.3M

Call Options Held

Put Options Held

View Full List

About Zomedica Corp.

Ticker ZOM
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 979,950,016
Market Cap $118M
Description
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...

More about ZOM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account